Measuring the influence of customer-based store brand equity in the purchase intention
subject: Store brand, Brand equity, purchase intention, retail, Structural Equation Modeling
description: Store brands account for and important market share in the Spain and a further increase in expected in the next years due to the downturn. However, there is lack of research on store brand customer-based Brand Equity. This study attempts to propose an integrated model of Brand Equity in store or retailer brands, based on Aaker’s well-known conceptual model. We propose a consumer-based model, including the main sources or dimensions of Brand Equity and considering the intention to purchase as a consequence. Based on a sample of 362 consu- mers and 5 store brands, structural equation modeling is used to test research hypotheses. The results obtained reveal that store brand awareness, loyalty along with store brand perceived quality have a significant influence on consumers’ intention to purchase store brands. Our study suggests that marketers and marketing managers from retailing companies should carefully consider the Brand Equity components when designing their brand strategies, and develop marketing activities in order to enhance their brands’ awareness.
creator: Cristina Calvo Porral, Valentín-Alejandro Martínez-Fernández, Óscar Juanatey-Boga, Jean-Pierre Lévy Mangin
source: Cuadernos de Gestión
publisher: Universidad del País Vasco (UPV/EHU)
date: 2015
language: EN, ES
identifier: DOI: 10.5295/cdg.130408cc
coverage: Commerce

https://www.socictopen.socict.org/items/show/872
title: Combining a Fusion Inhibitory Peptide Targeting the MERS-CoV S2 Protein HR1 Domain and a Neutralizing Antibody Specific for the S1 Protein Receptor-Binding Domain (RBD) Showed Potent Synergism against Pseudotyped MERS-CoV with or without Mutations in RBD
subject: MERS-CoV, RBD, mutation, peptide, neutralizing antibody, Combination
description: Middle East respiratory syndrome coronavirus (MERS-CoV) has continuously posed a threat to public health worldwide, yet no therapeutics or vaccines are currently available to prevent or treat MERS-CoV infection. We previously identified a fusion inhibitory peptide (HR2P-M2) targeting the MERS-CoV S2 protein HR1 domain and a highly potent neutralizing monoclonal antibody (m336) specific to the S1 spike protein receptor-binding domain (RBD). However, m336 was found to have reduced efficacy against MERS-CoV strains with mutations in RBD, and HR2P-M2 showed low potency, thus limiting the clinical application of each when administered separately. However, we herein report that the combination of m336 and HR2P-M2 exhibited potent synergism in inhibiting MERS-CoV S protein-mediated cell–cell fusion and infection by MERS-CoV pseudoviruses with or without mutations in the RBD, resulting in the enhancement of antiviral activity in contrast to either one administered alone. Thus, this combinatorial strategy could be used in clinics for the urgent treatment of MERS-CoV-infected patients.
creator: Cong Wang, Chen Hua, Shuai Xia, Weihua Li, Lu Lu, Shibo Jiang
source: Viruses
publisher: MDPI AG
date: 2019
language: EN
identifier: DOI: 10.3390/v11010031
coverage: Microbiology

Transdifferentiation is a driving force of regeneration in Halisarca dujardini (Demospongiae, Porifera)
subject: sponges, regeneration, morphogenesis, Epithelial to Mesenchymal Transition, transdifferentiation, Halisarca dujardini
description: The ability to regenerate is widespread in the animal kingdom, but the regenerative capacities and mechanisms vary widely. To understand the evolutionary history of the diverse regeneration mechanisms, the regeneration processes must be studied in early-evolved metazoans in addition to the traditional bilaterian and cnidarian models. For this purpose, we have combined several microscopy techniques to study mechanisms of regeneration in the demosponge Halisarca dujardini. The objectives of this work are to detect the cells and morphogenetic processes involved in Halisarca regeneration. We show that in Halisarca there are three main sources of the new exopinacoderm during regeneration: choanocytes, archaeocytes and (rarely) endopinacocytes. Here we show that epithelial-to-mesenchymal transition (EMT) and mesenchymal-to-epithelial transition (MET) occur during Halisarca regeneration. EMT is the principal mechanism during the first stages of regeneration, soon after the injury. Epithelial cells from damaged and adjacent intact choanocyte chambers and aquiferous canals assume mesenchymal phenotype and migrate into the mesohyl. Together with archaeocytes, these cells form an undifferentiated cell mass beneath of wound, which we refer to as a blastema. After the blastema is formed, MET becomes the principal mechanism of regeneration. Altogether, we demonstrate that regeneration in demosponges involves a variety of processes utilized during regeneration in other animals (e.g., cell migration, dedifferentiation, blastema formation) and points to the particular importance of transdifferentiation in this process. Further studies will be needed to uncover the molecular mechanisms governing regeneration in sponges.
creator: Ilya E. Borisenko, Maja Adamska, Daria B. Tokina, Alexander V. Ereskovsky
source: PeerJ
publisher: PeerJ Inc.
date: 2015
language: EN
identifier: DOI: 10.7717/peerj.1211
coverage: Medicine

Salinalona gen. nov., an euryhaline chydorid lineage (Crustacea: Branchiopoda: Cladocera: Anomopoda) from the Oriental region
subject: Salinalona gen.nov, Euryalona, Alona sarasinorum, Chydoridae, Cladocera, southern Thailand
description: Until now, a single endemic cladoceran genus was known from the Oriental region. We propose the region’s second endemic lineage of generic rank, Salinalona gen. nov., to accomodate the South East Asian Alona sarasinorum Stingelin, 1900 and the Indian A. taraporevalae Shirgur and Naik, 1977. Morphological revision shows that the external similarities with Alona Baird, 1843 or Leberis Smirnov, 1969 and Celsinotum Frey, 1991 that have been proposed in the past, are the result of convergence. The small lineage is euryhaline, even halophylic, an unusual adaptation in the order Anomopoda and particularly in the family Chydoridae. We discuss the position and adaptation of Salinalona gen. nov., such as a strongly modified hook on the first limb, based on a detailed study of populations from Maikhao peat swamp, Phuket island, Thailand. We include comparative notes on the circumtropical genus Euryalona Sars, 1901, with detailed morphology of the Asian E. orientalis (Daday, 1898). A key to all species of both genera is included.
creator: Kay Van Damme, Supiyanit Maiphae
source: Journal of Limnology
publisher: PAGEPress Publications
date: 2013
language: EN
identifier: DOI: 10.4081/jlimnol.2013.s2.e9
coverage: Environmental sciences, Geography. Anthropology. Recreation, Physical geography

Genetic lesions within the 3a gene of SARS-CoV
description: Abstract A series of frameshift mutations within the 3a gene has been observed in culture-derived severe acute respiratory syndrome coronavirus (SARS-CoV). We report here that viral RNA from clinical samples obtained from SARS-CoV infected patients also contains a heterogeneous population of wild-type and mutant 3a transcripts.
creator: Lim Seng, Shen Shuo, Chou Chih-Fong, Fielding Burtram C, Barkham Timothy, Tan Timothy HP, Hong Wanjin, Tan Yee-Joo
source: Virology Journal
publisher: BMC
date: 2005
language: EN
identifier: DOI: 10.1186/1743-422X-2-51
coverage: Infectious and parasitic diseases

Complications in critically ill adult patients’ transportations reported in the recent literature
subject: severe acute respiratory syndrome, extracorporeal membrane oxygenation, transportation of patients, Mobile emergency unit
description: The transport of critically ill patients is a complex process, made up by several phases involving the healthcare professionals. It requires a careful planning for the prevention of potential complications undermining the patients’ safety outside critical care environment. Literature review about complications and adverse events reported during intra and inter-hospital transport of critically ill adult patients. Intra-hospital transfers are affected by adverse events rates ranging from 22.2 to 75.7% in the published literature. Major adverse events, defined as life threatening conditions that require urgent therapeutic intervention, vary from 4.2 to 31%. Death is a rare occurrence. Adverse events during interhospital have a maximum rate of 34%. Technical incidents represent a typical feature of these transports. Authors reported problems to gas supply, ambulance electric system, equipment. There is a lack of studies about the complications related to rotary wing inter-hospital transports. While extracorporeal membrane oxygenation/extracorporeal life support patients seem to be the most complex category of critically ill to be transported outside the hospital, 11 papers revealed only 29 adverse events ranging from 0 to 17%. No deaths were recorded. Currently, research must explore more accurately how much transports affect the outcome of patients, and what are the most appropriate time-frames to assess the consequences of transfers on patients’ clinical conditions.
creator: Stefano Bambi, Alberto Lucchini, Diego Innocenti, Elisa Mattiussi
source: Emergency Care Journal
publisher: PAGEPress Publications
date: 2015
language: EN, IT
identifier: DOI: 10.4081/ecj.2015.4781
coverage: Medicine (General)

Strategy and technology to prevent hospital-acquired infections: Lessons from SARS, Ebola, and MERS in Asia and West Africa
subject: SARS, Ebola, MERS, infection control, Hospital acquired infections, Strategy
description: Abstract Hospital-acquired infections (HAIs) are serious problems for healthcare systems, especially in developing countries where public health infrastructure and technology for infection preventions remain undeveloped. Here, we characterized how strategy and technology could be mobilized to improve the effectiveness of infection prevention and control in hospitals during the outbreaks of Ebola, Middle East respiratory syndrome (MERS), and severe acute respiratory syndrome (SARS) in Asia and West Africa. Published literature on the hospital-borne outbreaks of SARS, Ebola, and MERS in Asia and West Africa was comprehensively reviewed. The results showed that healthcare systems and hospital management in affected healthcare facilities had poor strategies and inadequate technologies and human resources for the prevention and control of HAIs, which led to increased morbidity, mortality, and unnecessary costs. We recommend that governments worldwide enforce disaster risk management, even when no outbreaks are imminent. Quarantine and ventilation functions should be taken into consideration in architectural design of hospitals and healthcare facilities. We also recommend that health authorities invest in training healthcare workers for disease outbreak response, as their preparedness is essential to reducing disaster risk.
creator: Sanjeewa Jayachandra Rajakaruna, Wen-Bin Liu, Yi-Bo Ding, Guangwen Cao
source: Military Medical Research
publisher: BMC
date: 2017
language: EN
identifier: DOI: 10.1186/s40779-017-0142-5
coverage: Medicine (General), Military Science

CD8+ T Cells Responding to the Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Delivered by Vaccinia Virus MVA in Mice
subject: MERS-CoV, MERS-CoV nucleocapsid protein, murine CD8+ T cell epitope, MVA vaccine
description: Middle East respiratory syndrome coronavirus (MERS-CoV), a novel infectious agent causing severe respiratory disease and death in humans, was first described in 2012. Antibodies directed against the MERS-CoV spike (S) protein are thought to play a major role in controlling MERS-CoV infection and in mediating vaccine-induced protective immunity. In contrast, relatively little is known about the role of T cell responses and the antigenic targets of MERS-CoV that are recognized by CD8+ T cells. In this study, the highly conserved MERS-CoV nucleocapsid (N) protein served as a target immunogen to elicit MERS-CoV-specific cellular immune responses. Modified Vaccinia virus Ankara (MVA), a safety-tested strain of vaccinia virus for preclinical and clinical vaccine research, was used for generating MVA-MERS-N expressing recombinant N protein. Overlapping peptides spanning the whole MERS-CoV N polypeptide were used to identify major histocompatibility complex class I/II-restricted T cell responses in BALB/c mice immunized with MVA-MERS-N. We have identified a H2-d restricted decamer peptide epitope in the MERS-N protein with CD8+ T cell antigenicity. The identification of this epitope, and the availability of the MVA-MERS-N candidate vaccine, will help to evaluate MERS-N-specific immune responses and the potential immune correlates of vaccine-mediated protection in the appropriate murine models of MERS-CoV infection.
creator: Svenja Veit, Sylvia Jany, Robert Fux, Gerd Sutter, Asisa Volz
source: Viruses
publisher: MDPI AG
date: 2018
language: EN
identifier: DOI: 10.3390/v10120718
coverage: Microbiology

SARS-Like Coronavirus WIV1-CoV Does Not Replicate in Egyptian Fruit Bats (Rousettus aegyptiacus)
subject: WIV1-CoV, coronavirus, emerging infectious diseases, Animal model
description: Severe acute respiratory syndrome (SARS)-like WIV1-coronavirus (CoV) was first isolated from Rhinolophus sinicus bats and can use the human angiotensin converting enzyme 2 (ACE2) receptor. In the current study, we investigate the ability of WIV1-CoV to infect Rousettus aegyptiacus bats. No clinical signs were observed throughout the experiment. Furthermore, only four oropharyngeal swabs and two respiratory tissues, isolated on day 3 post inoculation, were found positive for viral RNA. Two out of twelve bats showed a modest increase in coronavirus specific antibodies post challenge. In conclusion, WIV1-CoV was unable to cause a robust infection in Rousettus aegyptiacus bats.
creator: Neeltje van Doremalen, Alexandra Schäfer, Vineet D. Menachery, Michael Letko, Trenton Bushmaker, Robert J. Fischer, Dania M. Figueroa, Patrick W. Hanley, Greg Saturday, Ralph S. Baric, Vincent J. Munster
source: Viruses
publisher: MDPI AG
date: 2018
language: EN
identifier: DOI: 10.3390/v10120727
coverage: Microbiology

Development of Small-Molecule MERS-CoV Inhibitors
subject: MERS-CoV, mechanism of action, Small molecule inhibitor
description: Middle East respiratory syndrome coronavirus (MERS-CoV) with potential to cause global pandemics remains a threat to the public health, security, and economy. In this review, we focus on advances in the research and development of small-molecule MERS-CoV inhibitors targeting different stages of the MERS-CoV life cycle, aiming to prevent or treat MERS-CoV infection.
creator: Ruiying Liang, Li-li WANG, Naru Zhang, Xiaoqian Deng, Meng SU, Yudan Su, Lanfang Hu, Chen He, Tianlei Ying, Shibo Jiang, Fei Yu
source: Viruses
publisher: MDPI AG
date: 2018
language: EN
identifier: DOI: 10.3390/v10120721
coverage: Microbiology